Le Lézard
Classified in: Health, Science and technology

Cybeats Announces Trial Evaluation with one of the World's Largest Software Companies


TORONTO, March 24, 2023 /PRNewswire/ - Cybeats Technologies Corp. ("Cybeats'' or the "Company")(CSE: CYBT) is pleased to announce the commencement of a trial evaluation with one of the top-3 largest software companies by total revenue, for Cybeats SBOM Studio.1

"The expressed interest from a software company of this magnitude further validates the growing demand for SBOM consumption and management worldwide and confirms the utility of SBOM Studio in addressing software supply chain needs globally. Our new client's outstanding reputation in the industry makes us proud to have the initial interest in our platform", said Yoav Raiter, CEO, Cybeats.

When large software companies adopt SBOM, a critical factor is the quality of the SBOMs generated and utilized in the organization. With the recently announced product feature, SBOM Quality Score, security teams at large software companies can validate their SBOM files before importing, ensuring that the file is correctly formatted according to the SBOM standard, and acting as 'quality control gates' for their SBOM ingestion processes.This functionality allows large security teams to significantly reduce the time spent on SBOM management, prioritize cybersecurity operations, and enhance their overall security posture.

As large software companies increasingly adopt software bill of materials (SBOM) at scale, a critical factor is the quality of the SBOMs generated and utilized across the organization. With the recently announced new SBOM Studio product feature2, SBOM Quality Score, security teams at large software companies can validate their SBOM files before importing, ensuring that the file is correctly formatted according to the SBOM standard, and acting as 'quality control gates' for their SBOM ingestion processes. This functionality builds on existing industry-leading capabilities to allow large security teams to significantly reduce the time spent on SBOM management, prioritize cybersecurity operations, and enhance their overall security posture.

Cybeats also recently announced that it has successfully completed 'System and Organization Controls' (SOC) 2 certification, achieving a significant organizational maturity milestone. SOC 2 certification provides credibility with customers in specific target verticals such as industrial controls, healthcare and software companies, where high levels of data security are essential.3

____________________________________ 
1 https://www.cybeats.com/sbom-studio
2 https://www.cybeats.com/news/pioneering-sbom-management-cybeats-launches-new-sbom-quality-score-feature-on-its-sbom-studio 
3 https://www.cybeats.com/news/cybeats-demonstrates-organizational-maturity-milestone-with-soc-2-certification 

Upcoming Events

Come meet us at Medical Device Playbook 2023 in Newport Beach on April 19, 2023! Discover new ideas to  deploy secure and resilient medical devices: https://meddevplaybook.com/newport-beach-2023/

Join us at RSA, Barcelona from April 24-27, 2023, the world's most influential IT conference, seeing 45,000 attendees each year: https://www.rsaconference.com/

About SBOM Studio

Cybeats' SBOM Studio enables organizations to efficiently manage, distribute, and view their software bill of materials (SBOMs) in a single interface. By doing so, they can easily identify and address cybersecurity vulnerabilities, reduce the cost of protection, and improve compliance. SBOM Studio is specifically designed to support software producers and consumers who use open source and 3rd party software components and who are transitioning to more transparent software development practices. The platform is compatible with various SBOM generation tools and can validate and correct imported SBOMs to improve their accuracy. With the recent addition of the SBOM Quality Score, the key features of SBOM Studio now include:

About Cybeats

Cybeats is a cybersecurity company providing SBOM management and software supply chain intelligence technology, helping organizations to manage risk, meet compliance requirements, and secure their software from procurement to development and operation. Our platform gives customers comprehensive visibility and transparency into their software supply chain, enabling them to improve operational efficiency and increase revenue. Cybeats. Software Made Certain. Website: https://cybeats.com 

SUBSCRIBE: For more information, or to subscribe to the Company's mail list, visit: https://www.cybeats.com/investors 

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law.   Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur.   Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE.  There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the commercialization plans for the products described in this news release will come into effect on the terms or time frame described herein.  The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law.  The reader is cautioned not to place undue reliance on forward-looking statements.  Company filings are available at sedar.com.

SOURCE Cybeats Technologies Corp.


These press releases may also interest you

at 01:21
RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting. Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating...

28 mai 2023
Aromatherapy designer Michael Hulbert, who, with his wife Anna, crafted over 30 best-selling aromatherapy blends in the last decade, announces the release of his comprehensive new book and guide, "Practical Aromatherapy for Everyday Living." This...

28 mai 2023
Harbour BioMed (the "Company", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics,...

28 mai 2023
The Concord Coalition said today that the budget and debt limit agreement reached by President Biden and Speaker McCarthy is a sound compromise that can be enacted in time to prevent any default on the federal government's legal obligations.  Concord...

28 mai 2023
The Honourable Marci Ien, Minister for Women and Gender Equality and Youth and Parliamentary Secretary Jenna Sudds issued the following statement today: "Period poverty is a worldwide sad reality, where many women, girls, non-binary individuals, and...

28 mai 2023
Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) today announced that the updated results of Phase Ib study of its CSF-1R inhibitor Pimicotinib (ABSK021) in treating patients with advanced tenosynovial giant cell tumor ("TGCT"), will...



News published on and distributed by: